Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates Life Science Investing
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference Life Science Investing
SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET Life Science Investing
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals Life Science Investing
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model Life Science Investing
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update Life Science Investing
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights Life Science Investing
Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma Technology Investing
Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
